- Supported exchanges /
- F /
- 6DW.F
D. Western Therapeutics Institute Inc (6DW F) stock market data APIs
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension. The company was founded in 1999 and is headquartered in Nagoya, Japan.
D. Western Therapeutics Institute Inc Financial Data Overview
| 0.32 | |
| 0.32 | |
| - | |
| 0.32 | |
| 0.32 | |
| 0.266-0.915 | |
| 14 368 K | |
| 36 075 K | |
| 464 M | |
| 0.723 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
D. Western Therapeutics Institute Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 464 M
- EBITDA -940 000 000
- Earnings Per Share -0.2
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get D. Western Therapeutics Institute Inc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get D. Western Therapeutics Institute Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
